Alogliptin and Metformin (KAZANO)
Questions a plan sponsor actually asks.
What is Alogliptin and Metformin used for?
Alogliptin and Metformin is tracked in Medicare Part D. Specific indication information is not available in our current dataset.
Is there a generic for Alogliptin and Metformin?
No. Alogliptin and Metformin is brand-only with no generic equivalents currently in market.
How much does my plan pay for Alogliptin and Metformin?
Across 329 Part D plans, Alogliptin and Metformin averages $2.39/unit (NADAC). Lowest available: $2.32/unit. Highest in distribution: $2.46/unit.
Is Alogliptin and Metformin on the FDA shortage list?
No. Alogliptin and Metformin is not currently on the FDA Drug Shortage Database.
4 additional drug-specific questions are indexed in the page's FAQPage schema for search engines and LLM crawlers, beyond what renders visually above. View page source for the complete JSON-LD.
Sources · every number above traces back.
Drug identity, dosage forms, brand names: openFDA NDC Directory · First approval, ANDA history: FDA Orange Book (6 approvals on file) · NADAC unit costs: CMS NADAC weekly file (2 NDCs benchmarked) · Formulary tier and PA placement: CMS Part D Formulary file (329 plans) · Annualized spend, claims, beneficiaries: CMS Part D Spending Dashboard · Shortage status: FDA Drug Shortage Database · 340B exposure: HRSA OPAIS. Methodology and reproducibility notes on /methodology.